Heterocyclic benzenesulfonylimine derivatives as inhibitors of IL-1 action
US5668143A · kind A · utility
20Cited by
5References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 3, 1996 |
| Grant date | Sep 16, 1997 |
| Priority date | — |
| Expiry date | Jul 3, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D311/68
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to heterocyclic benzenesulfonylimine derivatives and their use as inhibitors of Interleukin-1 (IL-1) action. Such inhibitors are useful in the treatment of various disease states as disclosed herein including rheumatoid arthritis, multiple sclerosis, diabetes mellitus, atherosclerosis, septic shock and pulmonary fibrosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.